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Pursuant to 24-A M.R.S.A. §4302(5), the Superintendent of Insurance must report information
annually to the Joint Standing Committee on Insurance and Financial Services related to
insurance claims made for the diagnosis and treatment of Lyme disease and other tick-borne
illnesses for all covered individuals in the State of Maine. This report covers calendar year 2012.
Included within this report is data about the number of claims made for the diagnosis and
treatment of Lyme disease and other tick-borne illnesses; the number of claim denials and
reasons for those denials; the number and outcome of internal appeals; the total dollar amounts
of those claims; and the number of external appeals related to the treatment of Lyme disease and
other tick-borne illnesses.
The Maine Center for Disease Control and Prevention identified five kinds of reported tick-borne
illnesses in Maine: Lyme disease, Babesiosis, Ehrlichiosis (Anaplasmosis), Rocky Mountain
Spotted Fever, and Powassan virus. Insurance carriers licensed to write health insurance
coverage in Maine are required to report to the Bureau of Insurance claims information for all
five tick-borne illnesses. Data is collected via an online reporting form and includes claims for
all insured Maine residents; however, the data does not include MaineCare or Medicare claims.
Respondents include active insurers with authority to write health insurance in Maine. There
was a 100% percent response rate from insurers.

Page 1

Tick-Borne Illness Claims by Category
Table 1 shows the number of claims submitted, paid and denied by category of tick-borne illness,
as well as the total amount paid for claims. The reported data includes claims made for the
diagnosis and treatment of tick-borne illnesses in the 2012 calendar year for covered individuals
in Maine. Five categories of tick-borne illnesses are listed based upon the International
Classification of Diseases (ICD-9 codes).
The figures in Table 1 represent the number of claims reported and not the number of enrollees
with a tick-borne illness. One enrollee may have several claims within the calendar year relating
to a tick-borne illness. The “Percentage of Claims Paid” column is calculated by dividing the
number of claims paid for a category (e.g., Lyme) by the number of claims submitted for that
category.
Table 1. Tick-Borne Illness Claims by Category, 2012
Category
Babesiosis
Ehrlichiosis
(Anaplasmosis)
Lyme disease
Powassan virus
Rocky Mountain
Spotted Fever
Total:

Submitted
24
41

Percentage
Paid
Denied of Claims
Paid
21
1
87.50%
36
4
87.80%

Total Paid
$2,481.21
$59,153.44

2,678
1
0

2,406
1
0

272
0
0

89.84%
100.00%
--

$696,720.94
$50.00
$0

2,744

2,464

277

89.80%

$758,405.59
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Reasons for Denied Tick-Borne Illness Claims
Table 2 provides the reasons given for denied claims payments related to any treatment for tickborne illnesses. A claim may have multiple reasons for denial. Over 53% of the reasons for
denial were either Duplicate Claim or Other Reason for Denial; the third highest category is Not
a Covered Benefit. Among the other reasons were: Charges applied to Deductible, Paid by
Medicare, Other Insurance is Primary, Payment Included in the Allowance of another Service,
Service Paid as Part of Major Procedure.
Table 2. Reasons for Denied Tick-Borne Illness Claims, 2012
Reasons for Denial
Duplicate Claim
Not a Covered Benefit
More Information Requested/Not Received
Coverage Terminated
Maximum Benefits Exceeded
Incorrect Coding
No Pre-Authorization
Not Medically Necessary
Considered Experimental/Investigational
Non-Participating Provider
Pre-existing conditions Exclusion
Other Reasons for Denial
Total:

Number of
Denied Claims

89
39
23
18
14
9
9
9
6
3
0
59
278
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Appeals/Reconsiderations and External Reviews for All Tick-Borne Illnesses
Table 3 provides the number of appeals and reconsiderations that were conducted by the
insurance companies reporting data to the Bureau of Insurance. The Bureau had no requests for
an independent external review relating to tick-borne illnesses in 2012.
Table 3. Number of Appeals/Reconsiderations and External Reviews for
All Tick-Borne Illnesses, 2012
Upheld

Appeals/Reconsideration (Internal)
Independent External Reviews
(Conducted by the Insurer,
not the Bureau of Insurance)
Total:

3
1

Overturned

4

0
0

Total

0

3
1
4

Lyme Disease Claims by Treatment Type
Table 4 shows the number of Lyme disease claims by type of treatment provided for covered
individuals. Claims for antibiotic treatment by any means of administration are counted.
The ‘Percent of Claims Paid’ column is calculated by dividing the number of claims paid for a
treatment type by the number of claims submitted for that treatment type. It is possible for
information about one enrollee to be entered in more than one category. For example, an
enrollee could have paid claims for antibiotics and have paid claims for other types of treatment,
such as physical therapy.
Prior to 2010, there were two separate categories for the duration of time that antibiotic treatment
lasted. For ease of reporting, the duration categories were eliminated in 2010, and there now is
one category for antibiotic treatment.
Some insurers provided detail about what “Other Treatment” meant. Among those reporting this
information, the majority of paid claims were for Osteopathic Manipulation.
Table 4. Lyme Disease Claims by Treatment Type, 2012
Treatment
Type
Antibiotic
Treatment
Other
Treatment
Total:

1,088

1,021

Percent
of
Claims
Paid
93.84%

1,669

1,391

2,757

2,412

Submitted

Paid
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Denied

Total Paid

67

$363,425.68

83.34%

269

$423,469.21

87.49%

336

$786,894.89

